Literature DB >> 30704699

Quality of life in idiopathic pulmonary fibrosis: The impact of sleep disordered breathing.

Marcello Bosi1, Giulia Milioli2, Liborio Parrino3, Francesco Fanfulla4, Sara Tomassetti1, Andrea Melpignano3, Irene Trippi3, Anna Elisabetta Vaudano3, Claudia Ravaglia1, Susanna Mascetti1, Venerino Poletti5.   

Abstract

PURPOSE: the study aims at describing the role of sleep disordered breathing (SDB) on daytime symptoms, quality of sleep and quality of life (QoL) in patients with moderate-severe IPF.
METHODS: we enrolled 34 consecutive room air breathing IPF outpatients who received a full-night polysomnography. The following questionnaires were administered: Epworth Sleepiness Score (ESS), Pittsburg Sleep Quality Index (PSQI), StGeorge's Questionnaire (StGQ).
RESULTS: patients were classified in 3 groups:Group A (NO-SDB, 9 patients), Group B(OSAS without sleep-related hypoxemia, 17 patients), Group C(OSAS with sleep-related hypoxemia, 8 patients). Although sleep parameters showed no significant differences among the 3 groups, worse measures were found in group C. 50% of patients (17/34) reported a StGQ score indicating a reduced QoL and the StGQ score was significantly higher in group C patients compared to group A (p < 0.05). In the stepwise multiple regression analysis, 75% of StGQ score variability was significantly predicted by FVC(Forced Vital Capacity) %, DLco (diffusion lung capacity for carbon monoxide)%, PSQI and ESS.
CONCLUSIONS: in patients with IPF both subjective and polysomnographic poor sleep quality are extremely common features, they are predicted by variables associated with SBD severity and are linked to low QoL. IPF with more severe SDB present poor sleep quality and a worse QoL compared to SDB-free or OSAS-only.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Idiopathic pulmonary fibrosis; Quality of life; Quality of sleep

Mesh:

Year:  2019        PMID: 30704699     DOI: 10.1016/j.rmed.2018.12.018

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

Review 1.  OSA and Chronic Respiratory Disease: Mechanisms and Epidemiology.

Authors:  Brian W Locke; Janet J Lee; Krishna M Sundar
Journal:  Int J Environ Res Public Health       Date:  2022-04-30       Impact factor: 4.614

Review 2.  Chinese Herbal Medicines Compared with N-Acetylcysteine for the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review of Randomized Controlled Trials.

Authors:  Jing Guo; Bin Li; Wenbin Wu; Zhichao Wang; Fei Wang; Taipin Guo
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-13       Impact factor: 2.629

3.  The prevalence of poor sleep quality and its associated factors in patients with interstitial lung disease: a cross-sectional analysis.

Authors:  Jin-Gun Cho; Alan Teoh; Mary Roberts; John Wheatley
Journal:  ERJ Open Res       Date:  2019-07-08

Review 4.  The Association between Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.

Authors:  Filip Franciszek Karuga; Piotr Kaczmarski; Bartosz Szmyd; Piotr Białasiewicz; Marcin Sochal; Agata Gabryelska
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.